Log-in / Create Account  
Session Information
2007 BIO International Convention
Click here to go to the previous page
Life After Merck KGaA v. Integra Life Science: Protecting and Licensing Research Tools
Track : Technology Transfer/Licensing
Program Code: TEC030
Date: Monday, May 7, 2007
Time: 4:00 PM to 5:30 PM  
Location: 258 C
CHAIR :
Thomas Parker, Partner, Alston & Bird LLP
SPEAKER (S):
Joshua Rosenkranz, Esq, Partner, Heller Ehrman, LLP
Becky Crump, PhD, Assistant Director Technology Transfer, Northwestern University
Brenda Manning, PhD, Director of Intellecutal Property Office, Children's Hospital Boston
Warren Woessner, Esq, Partner, Schwegman, Ludgerg, Woessner, Kluth, LLP
Description
The U.S. Supreme Court's decision in Merck v. Integra declined to address whether the "safe harbor" provision exempts use of research tools from patent infringement. This discussion will cover how research tool developers— universities, nonprofit research organizations and small biotech companies can address the aftermath of the Merck decision from different perspectives: (1) claim drafting, (2) trade secrets and (3) licensing.



Objectives:
  • Provide BIO members a comprehensive discussion of the current legal landscape of research tool patents post-Merck.

  • Identify current and future legal challenges for research tool developers.

  • Discuss alternatives to patenting research tools for strategic protection and strategies for licensing research tools.

    • Streaming Audio with
    PowerPoint Slides
    (Code: TEC030)
      
    This session is a part of:
    Technology Transfer/Licensing 2-DAY TRACK
    Complete Set of BIO Online / CD-ROM - All 23 Tracks.